“…The upregulation of Nfkbia by CR, in several tissue types (liver, heart, muscle, hypothalamus and lung), could therefore be an important mechanism by which CR inhibits the NF-κB pathway, with consequent effects on lifespan. An alternative possibility is that CR activates Sirt1, which then deacetylases components of the NF-κB complex (Yeung et al, 2004b;Ghosh et al, 2007;Salminen et al, 2008; but see Barger et al, 2008). Previous studies have indeed found that NF-κB signaling is inhibited by caloric restriction in both rodents and humans (Phillips and Leeuwenburgh, 2005;Dirks and Leeuwenburgh, 2006;Weiss et al, 2006;Ugochukwu and Figgers, 2007), and that inhibition of NF-κB blocks the accumulation of beta-amyloid plaques in Alzheimer's mice (Paris et al, 2007), as well as neoplastic transformation of cells during the initial stages of cancer (Karin, 2006).…”